[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR063446A1 - Sistema de administracion para el tratamiento remoto de un animal - Google Patents

Sistema de administracion para el tratamiento remoto de un animal

Info

Publication number
AR063446A1
AR063446A1 ARP070104871A ARP070104871A AR063446A1 AR 063446 A1 AR063446 A1 AR 063446A1 AR P070104871 A ARP070104871 A AR P070104871A AR P070104871 A ARP070104871 A AR P070104871A AR 063446 A1 AR063446 A1 AR 063446A1
Authority
AR
Argentina
Prior art keywords
administration system
animal
remote treatment
treatment
remote
Prior art date
Application number
ARP070104871A
Other languages
English (en)
Inventor
Grant Weyer
Simon R S Trickey
Timothy D Rose
Original Assignee
Veterinary Encapsulation Biosc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veterinary Encapsulation Biosc filed Critical Veterinary Encapsulation Biosc
Publication of AR063446A1 publication Critical patent/AR063446A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F42—AMMUNITION; BLASTING
    • F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
    • F42B12/00—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material
    • F42B12/02—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect
    • F42B12/36—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information
    • F42B12/40—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information of target-marking, i.e. impact-indicating type
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F42—AMMUNITION; BLASTING
    • F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
    • F42B12/00—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material
    • F42B12/02—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect
    • F42B12/36—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information
    • F42B12/46—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information for dispensing gases, vapours, powders or chemically-reactive substances
    • F42B12/54—Projectiles, missiles or mines characterised by the warhead, the intended effect, or the material characterised by the warhead or the intended effect for dispensing materials; for producing chemical or physical reaction; for signalling ; for transmitting information for dispensing gases, vapours, powders or chemically-reactive substances by implantation, e.g. hypodermic projectiles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Combustion & Propulsion (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un sistema de administracion remota para tratamiento que comprende un proyectil de dosaje substancialmente no-penetrante de la piel conteniendo un agente biologico activo y un portador transdérmico.
ARP070104871A 2006-11-01 2007-11-01 Sistema de administracion para el tratamiento remoto de un animal AR063446A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85574506P 2006-11-01 2006-11-01

Publications (1)

Publication Number Publication Date
AR063446A1 true AR063446A1 (es) 2009-01-28

Family

ID=39343692

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070104871A AR063446A1 (es) 2006-11-01 2007-11-01 Sistema de administracion para el tratamiento remoto de un animal

Country Status (6)

Country Link
US (3) US8425932B2 (es)
AR (1) AR063446A1 (es)
AU (1) AU2007314150B2 (es)
BR (1) BRPI0716696B1 (es)
MX (1) MX2009004620A (es)
WO (1) WO2008052263A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
BRPI0716696B1 (pt) 2006-11-01 2020-01-21 Smartvet Pty Ltd sistema de aplicação para tratamento remoto
ES2672634T3 (es) * 2007-06-07 2018-06-15 Bayer Animal Health Gmbh Control de ectoparásitos
US8404260B2 (en) 2008-04-02 2013-03-26 Bayer Cropscience Lp Synergistic pesticide compositions
FR2933298B1 (fr) * 2008-07-01 2015-05-22 Greenvet Poudre galenique triphasee a usage veterinaire a destination des oiseaux servant a vehiculer des agents actifs tels que: insecticides,insectifuges et tout autres substances
GB2464449B (en) * 2008-09-05 2011-10-12 Norbrook Lab Ltd A topical ectoparasticide composition
CN102599175A (zh) * 2008-12-31 2012-07-25 浙江世佳科技有限公司 藻酸丙二醇酯和阿维菌素的乳油
CN102613215A (zh) * 2008-12-31 2012-08-01 浙江世佳科技有限公司 藻酸丙二醇酯和甲胺基阿维菌素苯甲酸盐的乳油
AU2011301767B2 (en) * 2010-09-13 2014-12-18 Smartvet Pty Ltd System for oral delivery of an agent to an animal
US10024623B2 (en) * 2010-09-19 2018-07-17 Dan Elkins Remote controlled animal dart gun
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US9549904B2 (en) 2012-06-06 2017-01-24 Thomas Bryan Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin
US9480669B2 (en) 2015-01-06 2016-11-01 The Regents Of The University Of California Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
EP2838509A4 (en) 2012-04-16 2015-03-11 Zemtsov Entpr Llc FORMULATIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
US9200877B1 (en) * 2012-05-02 2015-12-01 Darren Rubin Biological active bullets, systems, and methods
AU2013204030B2 (en) 2012-06-22 2016-04-21 Smartvet Pty Ltd Dosage Regime for Animal Treatment
US20140121230A1 (en) * 2012-11-01 2014-05-01 Emmanuel Gonzales De Asis Topical parasiticidal formulation
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
EP2994115A4 (en) * 2013-05-10 2016-12-14 Smartvet Pty Ltd DOSING FLOOR FOR REMOVED TREATMENT OF ANIMAL
US9470489B2 (en) * 2013-05-14 2016-10-18 Kerry Thaddeus Bowden Airsoft marking round
CN104030992B (zh) * 2014-03-20 2016-03-23 东南大学 一种地昔尼尔药物晶型ⅱ及其制备方法
CL2014000989A1 (es) * 2014-04-17 2014-10-17 Univ Santiago Chile Dispositivo subdermal de liberacion prolongada y lenta para prevencion, tratamiento y monitoreo de parasitos, que comprende al menos una lactona macrociclica tal como ivermectina y/o dormectina, opcionalmente nanoparticulas o microparticulas de zeolita, una matriz polimerica y medios de monitoreo, dentro de un circuito integrado.
US9234729B2 (en) 2014-06-05 2016-01-12 Pneu-Dart, Inc. Injection dart
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US20170027677A1 (en) * 2015-07-27 2017-02-02 The United States Of America, As Represented By The Secretary Of Agriculture Dart Delivery System
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition
US10077976B2 (en) 2016-09-28 2018-09-18 BRT Medical LLC Illuminating assembly, projectile and projectile tail
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11382885B2 (en) 2017-06-07 2022-07-12 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US20220146242A1 (en) * 2019-02-27 2022-05-12 Smartvet Pty Ltd Dosage projectile and method of manufacture
US20200282014A1 (en) * 2019-03-05 2020-09-10 Hoffman Technologies Llc Percutaneous anti-microbiota formulations
CN110680803A (zh) * 2019-10-17 2020-01-14 广东省农业科学院动物卫生研究所 一种塞拉菌素醇质体制剂及其制备方法和应用
CN114259464B (zh) * 2021-11-25 2022-11-22 吉林大学 一种复方莫昔克丁外用滴剂
US12109176B1 (en) 2023-04-20 2024-10-08 Thomas Bryan Effect of glycerol on biofilm forming bacteria and fungi that changes the microbes sensitivity to pro and anti-biofilm non-toxic, non-bonded plasma amino acids and amino acid derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3528662A (en) * 1967-08-28 1970-09-15 John M Merchant Material dispensing projectile
JPH07143836A (ja) 1993-11-24 1995-06-06 Makoto Nishimura こませの撒布方法及びこれに使用するこませ並びにガン
WO1996003862A1 (en) 1994-08-01 1996-02-15 Deborah Hellings A non-toxic, edible, and biodegradable skeet and method of making the same
NL9401534A (nl) * 1994-09-21 1996-05-01 Gijsbertus Gerardus Petrus Van Gebruik van zetmeel voor parenterale toepassingen.
US6393992B1 (en) * 1996-11-18 2002-05-28 Jaycor Tactical Systems, Inc. Non-lethal projectile for delivering an inhibiting substance to a living target
GB0018593D0 (en) * 2000-07-28 2000-09-13 Brydges Price Richard I Projectile for delivery of a tranquilliser
WO2002060251A2 (en) 2001-01-19 2002-08-08 International Fly Masters, Inc. Chemical agent delivery device and method of using same
AU773534B2 (en) * 2001-08-15 2004-05-27 Nch Corporation Control agent delivery system and method of use
ZA200501028B (en) * 2004-02-09 2005-10-26 Simon Robert Sandford Trickey Administration of externally administered treatment substances to animals
BRPI0716696B1 (pt) 2006-11-01 2020-01-21 Smartvet Pty Ltd sistema de aplicação para tratamento remoto

Also Published As

Publication number Publication date
US20130216483A1 (en) 2013-08-22
US9238001B2 (en) 2016-01-19
BRPI0716696A2 (pt) 2014-03-04
WO2008052263A1 (en) 2008-05-08
AU2007314150A1 (en) 2008-05-08
AU2007314150B2 (en) 2009-06-04
US8425932B2 (en) 2013-04-23
US20100203122A1 (en) 2010-08-12
MX2009004620A (es) 2009-05-15
US8802135B2 (en) 2014-08-12
US20140341815A1 (en) 2014-11-20
BRPI0716696B1 (pt) 2020-01-21

Similar Documents

Publication Publication Date Title
AR063446A1 (es) Sistema de administracion para el tratamiento remoto de un animal
WO2010056922A3 (en) Systems and methods for delivery of biologically active agents
ATE489048T1 (de) Vorrichtung für kombinierte behandlung
CR20120345A (es) Derivados de 3-hidroxi-5-arilisotiazol novedosos
AR063135A1 (es) Sistema dosificador de medicamento por medio de una microbomba
ECSP088681A (es) Dispositivo de distribución de fármaco
DE602007007202D1 (de) Mikrokathetervorrichtungen und verfahren für gezielte wirkstofffreisetzung
CL2014003509A1 (es) Composición veterinaria masticable blanda que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal (div. sol. n°2087-14).
WO2011039736A3 (en) Device and method for drug delivery to a targeted skin layer
AR064268A1 (es) Sistema terapeutico transdermico para administracion del principio activo buprenorfina
AR042815A1 (es) Dispositivo de suministro de agente activo que tiene miembros compuestos
BRPI0810899A2 (pt) Formulação de nanopartículas de plga ativadas carregadas com agente ativo para substâncias nano-terapêuticas anticâncer direcionais.
CL2013001202A1 (es) Metodo para prevenir enfermedades de plantas que comprende aplicar un agente para el tratamiento del suelo, donde el agente comprende compuestos derivados de quinolina o sus sales como ingrediente activo.
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
BR112013012117A8 (pt) Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano
CY1113575T1 (el) Χρηση συνθεσεων οπιοειδων σε συσκευες χορηγησης δραστικης ουσιας χωρις βελονα
UY30790A1 (es) Combinacion de dos agentes antiparasitarios, en particular un derivado de 1-aril-4-ciclopropilpirazol y un agente antihelmintico y aplicaciones
RU2012157473A (ru) Способ выявления или лечения реакции "трансплантат против хозяина"
BRPI0820941A2 (pt) Uso de combinações de substâncias ativas para o combate de parasitas de animais.
BR112015004110A2 (pt) sistemas e métodos de distribuição de drogas para tratamento de próstata
AR066864A1 (es) Composicion parasiticida veterinaria, uso de la misma y metodo para el tratamiento o control de una infestacion o infeccion parasiticida en un animal homeotermico
BR112012014107A2 (pt) sistema terapêutico transdérmico para administração de peptídeos
CR20150044A (es) Formulación transdérmica que contiene inhibidores de cox
BR112015023917A2 (pt) método para determinar a atividade de forma potenciada ativada de substância
UY31059A1 (es) Formulaciones de aminoacido n-halogenado

Legal Events

Date Code Title Description
FG Grant, registration